IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q3 2024 Holdings

Filed 2024-11-14 | 14 holdings | $131.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Spdr S&P 500 ETF TR(SPY)PutTR UNIT78462F103$43.0M75,00032.6%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$15.4M795,81311.7%
Blueprint Medicines Corp(2L9)COM09627Y109$11.5M124,6008.7%
Kymera Therapeutics Inc(KYMR)COM501575104$9.9M208,7437.5%
Regenxbio Inc(RGNX)COM75901B107$9.8M930,7087.4%
Arvinas Inc(ARVN)COM04335A105$9.6M388,7667.3%
Merus N VCOMN5749R100$5.9M117,8554.5%
Silence Therapeutics PLC(SLN)ADS82686Q101$5.8M317,2144.4%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$4.1M181,9113.1%
Immatics N.v(IMTX)SHSN44445109$3.8M333,5022.9%
Adicet BIO Inc(TORCEUR)COM007002108$3.6M2,531,1942.8%
Precision Biosciences Inc(DTIL)COM NEW74019P207$3.4M381,8032.6%
Repare Therapeutics Inc(RPTX)COM760273102$3.4M989,3642.6%
Sutro Biopharma IncCOM869367102$2.6M762,4982.0%